Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_1
1
20%
Ph not_applicable
2
40%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Recruiting1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
N/A2 (40.0%)

Trials by Status

unknown120%
withdrawn120%
recruiting120%
completed120%
active_not_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization

NCT07241884
active_not_recruitingphase_2

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases

NCT03457948
completedphase_2

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

NCT02695628
withdrawnphase_1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

NCT05490381
unknownnot_applicable

ARTERIAL EMBOLIZATION OF PERSISTENT GENICULATE ARTERIES FOR CHRONIC PAIN MANAGEMENT AFTER TOTAL KNEE-REPLACEMENT ARTHROPLASTY(KNEE EMBOLISATION)

NCT04417686

Clinical Trials (5)

Showing 5 of 5 trials
NCT07241884Not Applicable

SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization

Recruiting
NCT03457948Phase 2

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases

Active Not Recruiting
NCT02695628Phase 2

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Completed
NCT05490381Phase 1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

Withdrawn
NCT04417686Not Applicable

ARTERIAL EMBOLIZATION OF PERSISTENT GENICULATE ARTERIES FOR CHRONIC PAIN MANAGEMENT AFTER TOTAL KNEE-REPLACEMENT ARTHROPLASTY(KNEE EMBOLISATION)

Unknown

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5